Tacrolimus 0.5 mg Oral Capsule
RxNorm 313190
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313190 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tacrolimus 0.5 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Tacrolimus 0.5 mg Oral Capsule
(Atom ID: 12339825)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely tacrolimus 500 microgram/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10317485)
SYPrescribable
Synonym (SY):
Tacrolimus 0.5 mg (as anhydrous tacrolimus) Oral Capsule
(Atom ID: 3545276)
PSNPrescribable
Prescribable Name (PSN):
Tacrolimus 0.5 mg Oral Capsule
(Atom ID: 6368925)
PTPrescribable
Designated preferred name (PT):
Tacrolimus 500 microgram oral capsule
(Atom ID: 10321312)
Patient Education
Tacrolimus
Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.
[Learn More]
* Please review the disclaimer below.